Sun Pharma Advanced Research Company Limited, a clinical-stage biopharmaceutical company, engages in the research and development of pharmaceutical products in India and internationally. It develops products with a therapeutic focus on oncology and immunology. The company is also developing Vodobatinib (SCO-088), a BCR-ABL inhibitor, for the treatment of refractory chronic myelogenous leukemia that is in phase 2 clinical trial; and Vibozilimod (SCD-044), a selective sphingosine-1-phosphate receptor 1 (S1PR1) agonist, for the treatment of psoriasis and atopic dermatitis that is in phase 2 clinical trial. In addition, it develops SCD-153 for the treatment of alopecia areata; and SBO-154, an anti-MUC-1 ADC, for the treatment of multiple tumors that is in preclinical trials. The company was incorporated in 2006 and is based in Mumbai, India.
Low
108.00
High
289.00
Low
191.91
High
197.00
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How Sun Pharma Advanced Research Company Limited stacks up against its Drug Manufacturers - Specialty & Generic peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SPARC Sun Pharma Advanced Research Company Limited | 192.91 | 0.01% | 3.94 | 48.91 | 6,260 | 26.23% | 18.90% | 289.00 / 108.00 |
| 2 | AARTIDRUGS Aarti Drugs Limited | 408.60 | 1.02% | 19.52 | 20.93 | 3,729 | 2.99% | 23.06% | 534.55 / 318.95 |
| 3 | AARTIPHARM Aarti Pharmalabs Limited | 834.80 | 4.55% | 35.52 | 23.50 | 7,570 | 18.08% | 12.10% | 946.10 / 585.00 |
| 4 | ABBOTINDIA Abbott India Limited | 26,355.00 | 0.85% | 34.68 | 759.88 | 55,932 | 4.13% | 23.14% | 33,185.00 / 25,150.00 |
| 5 | AHCL ANLON HEALTHCARE LIMITED | 14.41 | 1.50% | 21.15 | 0.68 | 766 | 7.15% | 58.35% | 17.27 / 9.08 |
| 6 | AJANTPHARM Ajanta Pharma Limited | 3,690.00 | 0.44% | 40.62 | 90.83 | 46,346 | 10.05% | 36.16% | 3,796.00 / 2,329.90 |
| 7 | AKUMS AKUMS DRUGS AND PHARMA L | 750.00 | 0.79% | 39.37 | 19.05 | 11,483 | 8.07% | 34.69% | 775.00 / 409.30 |
| 8 | ALIVUS Alivus Life Sciences Limited | 1,365.00 | 2.41% | 27.84 | 49.03 | 16,758 | 17.11% | 28.28% | 1,418.00 / 819.00 |
| 9 | ALKEM Alkem Laboratories Limited | 5,380.50 | 1.73% | 29.82 | 180.45 | 64,332 | 4.18% | 9.07% | 5,933.50 / 5,075.00 |
| 10 | AMRUTANJAN Amrutanjan Health Care Limited | 499.05 | 2.21% | 26.73 | 18.67 | 1,437 | 6.72% | 30.68% | 790.95 / 482.80 |
| 11 | APLLTD Alembic Pharmaceuticals Limited | 814.20 | 1.26% | 23.09 | 35.27 | 16,110 | 3.07% | 20.99% | 1,002.00 / 635.80 |
| 12 | ASTRAZEN AstraZeneca Pharma India Limited | 7,500.00 | 1.90% | 110.54 | 67.85 | 18,750 | 7.84% | 18.57% | 9,849.50 / 7,481.00 |
| 13 | AUROPHARMA Aurobindo Pharma Limited | 1,616.00 | 1.76% | 25.25 | 64.00 | 93,800 | 3.27% | 40.30% | 1,682.40 / 1,016.10 |